At Lancaster General Health, we offer some of the latest approaches in lung cancer screening and diagnostics, including a program for early detection, and advanced tools like molecular diagnostics that can lead to more targeted therapies for better outcomes. We also offer a variety of resources to help you quit smoking and prevent lung cancer in the first place.
Thoracic surgeon Dr. David Cziperle discusses how lung cancer is different in men and women; symptoms to look for; and advanced treatment options available at Penn Medicine Lancaster General Health.

Early Detection for High-risk Patients

Lung cancer is the leading cause of cancer deaths in the United States—more than breast, prostate, and colon cancers combined. As with most cancers, early detection of lung cancer offers the best opportunity for a cure. Our low-dose CT screening program is the only recommended tool for detecting lung cancer in its earliest stage—before symptoms are apparent. This method of early detection has been proven to reduce the risk of lung cancer death by 20%.

If you are a current or former smoker who is concerned about your risk for developing lung cancer, find out if you may be a candidate for this important screening test.

Advanced Diagnostics for Lung Cancer

Accurate diagnosis and staging (determining if cancer has spread) is critical for patients with lung cancer. Your team at Lancaster General Health includes surgeons, pulmonologists, medical oncologists, diagnostic radiologists and pathologists with access to a full range of sophisticated diagnostic tools to help them develop an individualized treatment plan. Our advanced diagnostic imaging technologies include:

  • Positron emission tomography (PET)
  • Computed tomography (CT)
  • Endoscopic ultrasound (EUS)
  • Endobrachial ultrasound (EBUS)
  • Bronchoscopy
  • Electromagnetic navigational bronchoscopy (ENB)
  • Magnetic resonance imaging (MRI)
  • Nuclear scans

Molecular Diagnostics: Precision Medicine

Molecular diagnostics, also known as precision medicine, involves the precise identification of the molecular or genetic changes in cancer cells compared to normal cells. Understanding these changes allows for the development of highly targeted therapies that affect only cancer cells—not normal cells. Targeted therapies are often much more successful and less toxic than traditional cancer treatments, such as chemotherapy.

LG Health has been a national leader in the implementation of advanced diagnostic testing for lung cancer. The Association of Community Cancer Centers, an organization whose membership represents over 60% of cancer care professionals in the U.S., has our molecular testing program as a best practice.

Smoking Cessation Programs

Quitting smoking is one of the best steps you can take for your health. We offer a variety of programs to help you live tobacco-free, including group classes and one-on-one counseling. Our Wellness program offers tobacco free living information and registration options.

You Might Also Be Interested In...

Share This Page: